Stockreport

PAVmed down 18% on extended review timeline for CarpX device [Seeking Alpha]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF PAVmed down 18% on extended review timeline for CarpX device [Read more]